Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects

被引:11
|
作者
Gershkovich, Marina [1 ,2 ]
Middleton, Rachel [1 ,2 ]
Hezel, Dianne M. [1 ,2 ]
Grimaldi, Stephanie [3 ]
Renna, Megan [4 ]
Basaraba, Cale [1 ]
Patel, Sapana [1 ,2 ]
Simpson, H. Blair [1 ,2 ]
机构
[1] New York State Psychiat Inst & Hosp, 1051 Riverside Dr, New York, NY 10025 USA
[2] Columbia Univ, Med Ctr, New York, NY 10027 USA
[3] Hofstra Univ, Hempstead, NY 11550 USA
[4] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
关键词
cognitive-behavioral therapy; treatment; OCD; mobile app; technology; COGNITIVE-BEHAVIORAL THERAPY; CONTROLLED-TRIAL; SELF-HELP; METAANALYSIS; SCALE; INTERVENTIONS; REMISSION; ANXIETY;
D O I
10.1016/j.beth.2020.05.001
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Many individuals with obsessive-compulsive disorder (OCD) do not receive evidence-based care (specifically exposure and ritual prevention; EX/RP) due to barriers such as a lack of EX/RP-trained clinicians, geographic obstacles, and the cost and time associated with the treatment. Offering an integrated treatment model consisting of brief in-person therapy coupled with a mobile application (app) might be one way to increase access to and reduce the time burden (to clinicians and patients) of EX/RP. This pilot trial evaluated the feasibility, acceptability, and clinical effects of such a treatment program for adults with OCD. Thirty-three participants enrolled in the 8-week open trial. The integrated treatment program consisted of 3 to 5 in-person sessions followed by weekly phone calls supported by a mobile app (nOCD). Participants were evaluated by trained raters and completed self-report measures at baseline, midtreatment, posttreatment and 2-month follow-up; the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was the primary outcome. This integrated treatment program was feasible and acceptable to participants. Of the 33 study entrants, 14 (42%) responded to treatment (Y-BOCS decrease >= 35% with CGI- of 1 or 2), and 8 (24%) achieved minimal symptoms (i.e., Y-BOCS <= 12). At 2-month follow-up (n=20), 7/20 (35%) met criteria for treatment response, and 3/20 (15.0%) met criteria for treatment remission. Although preliminary, this model warrants further study as an efficacious and resource-efficient way to deliver EX/RP for some patients with OCD.
引用
收藏
页码:394 / 405
页数:12
相关论文
共 50 条
  • [21] The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder
    Williams, Monnica T.
    Farris, Samantha G.
    Turkheimer, Eric N.
    Franklin, Martin E.
    Simpson, H. Blair
    Liebowitz, Michael
    Foa, Edna B.
    JOURNAL OF ANXIETY DISORDERS, 2014, 28 (06) : 553 - 558
  • [22] Serious negative consequences associated with exposure and response prevention for obsessive-compulsive disorder: A survey of therapist attitudes and experiences
    Schneider, Sophie C.
    Knott, Lindsey
    Cepeda, Sandra L.
    Hana, Lynn M.
    McIngvale, Elizabeth
    Goodman, Wayne K.
    Storch, Eric A.
    DEPRESSION AND ANXIETY, 2020, 37 (05) : 418 - 428
  • [23] A systematic review and meta-analysis on the effectiveness of exposure and response prevention therapy in the treatment of Obsessive-Compulsive Disorder
    Ferrando, Cloe
    Selai, Caroline
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2021, 31
  • [24] Symptom Dimensions in Obsessive-Compulsive Disorder: Phenomenology and Treatment Outcomes with Exposure and Ritual Prevention
    Williams, Monnica T.
    Mugno, Beth
    Franklin, Martin
    Faber, Sonya
    PSYCHOPATHOLOGY, 2013, 46 (06) : 365 - 376
  • [25] Delivery of Exposure and Response Prevention Among Veterans with Obsessive-Compulsive Disorder
    Hertz, Alyssa G.
    Dawson, Darius B.
    Rassu, Fenan S.
    Ecker, Anthony H.
    Helm, Ashley
    Hundt, Natalie E.
    Fletcher, Terri L.
    JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2023, 50 (04): : 514 - 523
  • [26] Intensive Exposure and Response Prevention for Adolescent Body Dysmorphic Disorder With Comorbid Obsessive-Compulsive Disorder and Major Depressive Disorder
    Le, Thien-An P.
    Merricks, Katie
    Nadeau, Joshua M.
    Ramos, Amaya
    Storch, Eric A.
    CLINICAL CASE STUDIES, 2017, 16 (06) : 480 - 496
  • [27] Patient adherence as a predictor of acute and long-term outcomes in concentrated exposure treatment for difficult-to-treat obsessive-compulsive disorder
    Tjelle, Kristian
    Opstad, Havard Berg
    Solem, Stian
    Kvale, Gerd
    Wheaton, Michael G.
    Bjorgvinsson, Throstur
    Hansen, Bjarne
    Hagen, Kristen
    BMC PSYCHIATRY, 2024, 24 (01)
  • [28] Comparing the Effectiveness of Schema Therapy Augmented Exposure and Response Prevention With Exposure and Response Prevention and Pharmacotherapy in Obsessive-compulsive Disorder
    Masoumian, Samira
    Gharraee, Banafsheh
    Farani, Abbas Ramezani
    Shaeiri, Mohammad Reza
    Asgharnejadfarid, Ali Asghar
    IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, 2022, 28 (02): : 162 - 181
  • [29] Development of a protocol for videoconferencing-based exposure and response prevention treatment of obsessive-compulsive disorder during the COVID-19 pandemic
    Kathiravan, Sanjana
    Chakrabarti, Subho
    WORLD JOURNAL OF PSYCHIATRY, 2023, 13 (02): : 60 - 74
  • [30] Behavioral avoidance predicts treatment outcome with exposure and response prevention for obsessive-compulsive disorder
    Wheaton, Michael G.
    Gershkovich, Marina
    Gallagher, Thea
    Foa, Edna B.
    Simpson, H. Blair
    DEPRESSION AND ANXIETY, 2018, 35 (03) : 256 - 263